Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Routes of Administration AHK-Cu's route in community use is topical only
Avoid disease-treatment claims, dosage instructions, or medical promises
The Benoist et al
Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
An ointment base for severely dry plaques, a gel for seborrheic areas, a foam for scalp application, a cream for cosmetically sensitive areas
